JP2022512676A5 - - Google Patents

Info

Publication number
JP2022512676A5
JP2022512676A5 JP2021519876A JP2021519876A JP2022512676A5 JP 2022512676 A5 JP2022512676 A5 JP 2022512676A5 JP 2021519876 A JP2021519876 A JP 2021519876A JP 2021519876 A JP2021519876 A JP 2021519876A JP 2022512676 A5 JP2022512676 A5 JP 2022512676A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
independently selected
substituents independently
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021519876A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512676A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/058591 external-priority patent/WO2020075080A1/en
Publication of JP2022512676A publication Critical patent/JP2022512676A/ja
Publication of JP2022512676A5 publication Critical patent/JP2022512676A5/ja
Withdrawn legal-status Critical Current

Links

JP2021519876A 2018-10-10 2019-10-09 大環状インフルエンザエンドヌクレアーゼ阻害剤 Withdrawn JP2022512676A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862744060P 2018-10-10 2018-10-10
US62/744,060 2018-10-10
PCT/IB2019/058591 WO2020075080A1 (en) 2018-10-10 2019-10-09 Macrocyclic flu endonuclease inhibitors

Publications (2)

Publication Number Publication Date
JP2022512676A JP2022512676A (ja) 2022-02-07
JP2022512676A5 true JP2022512676A5 (https=) 2022-10-17

Family

ID=68242803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021519876A Withdrawn JP2022512676A (ja) 2018-10-10 2019-10-09 大環状インフルエンザエンドヌクレアーゼ阻害剤

Country Status (10)

Country Link
US (2) US11312727B1 (https=)
EP (1) EP3864020A1 (https=)
JP (1) JP2022512676A (https=)
KR (1) KR20210074329A (https=)
CN (1) CN113195502A (https=)
AU (1) AU2019359539A1 (https=)
CA (1) CA3115792A1 (https=)
MX (1) MX2021004182A (https=)
TW (1) TW202035424A (https=)
WO (1) WO2020075080A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY201239A (en) 2019-03-22 2024-02-13 Gilead Sciences Inc Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
WO2021191872A1 (en) * 2020-03-26 2021-09-30 Janssen Biopharma, Inc. Heteroaryl-substituted macrocyclic flu endonuclease inhibitors
CN113444010B (zh) * 2020-03-28 2023-09-05 南京正大天晴制药有限公司 一种沙芬酰胺有关物质的制备方法
JP7407976B2 (ja) * 2020-05-21 2024-01-04 シーセン ファーマシューティカル カンパニー リミテッド 縮合環誘導体及びその薬学的用途
WO2021249522A1 (zh) * 2020-06-12 2021-12-16 上海翰森生物医药科技有限公司 含吡啶酮稠环类衍生物抑制剂、其制备方法和应用
ES3064867T3 (en) 2020-09-30 2026-04-29 Gilead Sciences Inc Bridged tricyclic carbamoylpyridone compounds for a use in the treatment of hiv
WO2022105669A1 (zh) * 2020-11-17 2022-05-27 南京明德新药研发有限公司 含Se大环类化合物
US11613546B2 (en) 2021-01-19 2023-03-28 Gilead Sciences, Inc. Substituted pyridotriazine compounds and uses thereof
EP4384178A4 (en) * 2021-08-11 2025-07-02 Merck Sharp & Dohme Llc POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF INFLUENZA
CN118317964A (zh) * 2021-11-17 2024-07-09 辰欣药业股份有限公司 一种稠环衍生物的晶型及其制备方法
WO2025015300A2 (en) * 2023-07-12 2025-01-16 Apac Pharma, Llc Hepoxilin analogs, methods, uses, and processes for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927710B2 (en) * 2009-06-15 2015-01-06 Shionogi & Co., Ltd. Substituted polycyclic carbamoylpyridone derivative
DK2620436T3 (en) * 2010-09-24 2018-07-30 Shionogi & Co Substituted polycyclic carbamoylpyridone derivative prodrug
SI3030549T1 (sl) * 2013-09-12 2019-08-30 Janssen Biopharma, Inc. Spojine piridazinona in njihove uporabe
JOP20170169A1 (ar) * 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو

Similar Documents

Publication Publication Date Title
JP2022512676A5 (https=)
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
JP2017523169A5 (https=)
RU2018128318A (ru) Селективные ингибиторы эстрогеновых рецепторов и их применение
JP2015531773A5 (https=)
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
JP2021513534A5 (https=)
JP2015537020A5 (https=)
RU2009109160A (ru) Инсектицидные изоксазолины
JP2014511891A5 (https=)
JP2016518437A5 (https=)
JP2016540742A5 (https=)
JP2015516427A5 (https=)
JP2014507455A5 (https=)
CL2019003857A1 (es) Composiciones y métodos de uso de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida solicitudes relacionadas.
JP2017531619A5 (https=)
JP2014506907A5 (https=)
JP2019510027A5 (https=)
JP2016514138A5 (https=)
JP2020502047A5 (https=)
JP2016540028A5 (https=)
JP2016531126A5 (https=)
RU2017145357A (ru) Пролекарство на основе фосфамида монобензилового сложного эфира тенофовира, способ его получения и применение
WO2019099564A8 (en) Novel imidazopyrimidine compounds and uses thereof
JP2015521195A5 (https=)